JY
HUMA icon

Jeff Yass’s Humacyte HUMA Stock Holding History

Jeff Yass’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
1,699,243
+641,195
+61% +$594K ﹤0.01% 7478
2026
Q1 		$642K Buy
1,058,048
+48,378
+5% +$50.3K ﹤0.01% 9022
2025
Q4 		$970K Sell
1,009,670
-133,363
-12% -$189K ﹤0.01% 7264
2025
Q3 		$1.99M Sell
1,143,033
-273,500
-19% -$536K ﹤0.01% 5807
2025
Q2 		$2.96M Buy
1,416,533
+858,026
+154% +$1.65M ﹤0.01% 4985
2025
Q1 		$952K Sell
558,507
-224,570
-29% -$843K ﹤0.01% 7382
2024
Q4 		$3.95M Buy
783,077
+226,107
+41% +$1.12M ﹤0.01% 3969
2024
Q3 		$3.03M Buy
556,970
+545,129
+4,604% +$3.59M ﹤0.01% 4520
2024
Q2 		$56.8K Sell
11,841
-111,791
-90% -$582K ﹤0.01% 11354
2024
Q1 		$384K Buy
123,632
+53,642
+77% +$180K ﹤0.01% 9122
2023
Q4 		$199K Sell
69,990
-5,443
-7% -$14K ﹤0.01% 10692
2023
Q3 		$221K Buy
75,433
+21,165
+39% +$70K ﹤0.01% 10017
2023
Q2 		$155K Buy
54,268
+22,901
+73% +$82.6K ﹤0.01% 10545
2023
Q1 		$96.9K Buy
31,367
+4,372
+16% +$12.4K ﹤0.01% 11317
2022
Q4 		$57K Sell
26,995
-50,660
-65% -$154K ﹤0.01% 11324
2022
Q3 		$253K Sell
77,655
-64,047
-45% -$246K ﹤0.01% 10247
2022
Q2 		$455K Sell
141,702
-155,998
-52% -$867K ﹤0.01% 8512
2022
Q1 		$2.1M Buy
+297,700
New +$1.73M ﹤0.01% 5367

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jeff Yass's HUMA Position: Q2 2026 in Review

Jeff Yass increased its Humacyte (HUMA) stake by 61% in Q2 2026, buying an estimated $594K and bringing the position to 1,699,243 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #7478.

Jeff Yass first reported a position in HUMA in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.95M in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Jeff Yass held 1,699,243 shares of Humacyte worth $1.33M as of Q2 2026.
  • Jeff Yass bought 641,195 Humacyte shares in Q2 2026, an estimated $594K.
  • Humacyte made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7478 holding.
  • Jeff Yass first reported a position in Humacyte in Q1 2022 and has held it in 18 quarters since.
  • Jeff Yass's Humacyte position peaked at $3.95M in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.